Catalog No.
Product Name
Application
Product Information
Citations
-
Anti-Bacterial Agent
Rhodirubin B is an anti-bacterial agent primarily targeting Gram-positive bacteria and exhibiting activity against Mycobacterium species. This compound has demonstrated the ability to enhance survival rates in mice inoculated with leukemia L-1210, indicating potential applications in cancer research and infectious disease studies. Rhodirubin B is valuable for investigating mechanisms of bacterial resistance and the interplay between infection and cancer. -
Bacterial Inhibitor
Kipukasin D is a natural nucleoside derived from Aspergillus versicolor, exhibiting potent antibacterial activity. It operates primarily as a bacterial inhibitor, making it valuable for research involving bacterial infections and microbial resistance mechanisms. This compound is useful for studies in pharmacology, microbiology, and drug development focused on identifying new antimicrobial agents. -
Bacterial Inhibitor
Antistaphylococcal agent 3 is a bacterial inhibitor that targets Staphylococcus species, disrupting their growth and proliferation. This compound exhibits potent antimicrobial activity, making it suitable for research applications focused on bacterial infection models and therapeutic development. Its efficacy against resistant strains renders it valuable for studies aimed at understanding staphylococcal pathogenesis and developing novel antibacterial strategies. -
Anti-Bacterial Agent
Rhodirubin A is an anti-bacterial agent primarily targeting Gram-positive bacteria and demonstrating efficacy against Mycobacterium species. In addition to its antibacterial properties, Rhodirubin A has been shown to extend the survival time in mice models inoculated with leukemia L-1210. This compound is valuable in research applications focused on infection control and cancer biology. -
Bacterial Inhibitor
DS-8587 is a novel fluoroquinolone designed as a bacterial inhibitor, demonstrating significant antibacterial activity against amoxicillin-resistant Bacillus strains. Its minimum inhibitory concentration (MIC) values outperform those of ciprofloxacin and levofloxacin, while exhibiting reduced susceptibility to efflux pump-mediated resistance mechanisms such as adeA/adeB/adeC and abeM. Additionally, DS-8587 has a lower single-step mutation frequency compared to ciprofloxacin, positioning it as a promising therapeutic candidate for the treatment of amoxicillin-resistant Bacillus infections. -
Bacterial Inhibitor
Urechistachykinin I is a tachykinin-related peptide derived from echiuroid worms, primarily targeting bacterial pathogens. This compound exhibits significant antimicrobial activity while demonstrating no hemolytic effects, making it a valuable reagent for research into antimicrobial mechanisms and agents. Its unique properties make it suitable for studies investigating bacterial inhibition in various biological contexts. -
Antibacterial/Anti-inflammatory Agent
Antibacterial Agent 115 is a potent antibacterial and anti-inflammatory compound. It demonstrates significant efficacy in inhibiting bacterial growth while simultaneously modulating inflammatory responses. This compound is suitable for research applications aimed at understanding bacterial resistance mechanisms and the development of novel therapeutic strategies for bacterial infections and related inflammatory conditions. -
Anti-bacterial Agent
Antibacterial Agent 204 (Compd P2-56-3) is an anti-bacterial agent that exhibits enhanced Rifampin activity against Acinetobacter baumannii and Klebsiella pneumoniae. This compound disrupts the outer membrane of A. baumannii, which contributes to its antimicrobial efficacy. Antibacterial Agent 204 is applicable in research focused on developing novel treatments for infections caused by resistant bacterial strains. -
Antibacterial Agent
Antibacterial agent 82 (compound 7p) functions as an antibacterial agent targeting bacterial growth and proliferation. It exhibits significant efficacy against a range of Gram-positive and Gram-negative bacteria, making it suitable for studies focused on antimicrobial resistance and infection control. This compound is ideal for use in pharmacological research, including the development of new antibacterial therapies and mechanisms underlying bacterial pathogenesis. -
Antibacterial Compound
(6E,12E)-Tetradecadiene-8,10-diyne-1,3-diol is an antibacterial compound known for its effectiveness against methicillin-resistant Staphylococcus aureus (MRSA), exhibiting minimum inhibitory concentration (MIC) values of 4-32 μg/mL. Isolated from the roots of Atractylodes japonica, this compound serves as a valuable tool in the study of bacterial infections. Additionally, it functions as a click chemistry reagent due to its alkyne group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with azide-containing molecules. -
Antifouling/Antibacterial Agent
Cochliomycin A is an antifouling and antibacterial agent derived from the Gorgonian-Derived Fungus Cochliobolus lunatus. It exhibits significant antifouling activity, with an EC50 of 1.2 μg/mL, effectively inhibiting barnacle larval settlement through stimulation of the NO/cGMP signaling pathway. Additionally, Cochliomycin A demonstrates moderate antibacterial efficacy against Staphylococcus aureus, making it valuable for research applications in marine biology and antimicrobial studies. -
Antibacterial Agent
Trospectomycin dihydrochloride is an antibacterial agent targeting bacterial ribosome function. This compound demonstrates broad-spectrum activity against various gram-positive and gram-negative bacteria. Trospectomycin dihydrochloride is suitable for research applications involving the study of bacterial infections and the evaluation of antibiotic resistance mechanisms. -
Antibacterial Agent
Furaltadone is a nitrofuran derivative that acts as an antibacterial agent primarily targeting gram-positive bacteria. It demonstrates both inhibitory and bactericidal effects against staphylococci in vitro. This compound is particularly relevant for research on bacterial infections, including those caused by Salmonella enteritidis in poultry, offering insights into its therapeutic potential in veterinary medicine. -
Antibacterial Agent
Armeniaspirol C is a potent antibacterial agent that specifically targets Gram-positive bacteria. This compound demonstrates significant efficacy against multidrug-resistant strains, making it a valuable candidate for research into infections caused by resistant Gram-positive pathogens. Its unique mechanism of action positions Armeniaspirol C as a promising tool for the development of new antibacterial therapies. -
Antibiotic
Amythiamicin C is an antimicrobial antibiotic that primarily targets Gram-positive bacteria, including strains of methicillin-resistant Staphylococcus aureus (MRSA). Additionally, it exhibits activity against Plasmodium falciparum, making it valuable for research in infectious diseases and antibiotic resistance. This compound is relevant for studies focused on the development of novel therapeutic strategies against resistant bacterial infections and malaria. -
Antibiotic
A51493A is an anthracyclinone antibiotic that exhibits potent antimicrobial activity against Gram-positive bacteria. This compound is useful in research applications focused on bacterial infections and exploring mechanisms of antibiotic resistance. Its unique structure and mode of action make it a valuable tool for studying antimicrobial efficacy and developing new therapeutic strategies. -
Antibiotic
Seldomycin factor 1 is an aminoglycoside antibiotic that targets bacterial protein synthesis. It exhibits a broad spectrum of antimicrobial activity against various Gram-positive and Gram-negative bacteria. This compound is valuable for research applications in microbiology and antibiotic resistance studies. -
Antibiotic
Chitinovorin C is a β-lactam antibiotic that primarily targets bacterial cell wall synthesis. It exhibits selective inhibitory activity against Gram-negative bacteria, making it a valuable tool in antibiotic research. This compound is utilized in studies aimed at understanding antibiotic resistance mechanisms and developing new therapeutic strategies against bacterial infections. -
Antibiotic
Spectinomycin sulfate hydrate is an antibiotic that primarily targets bacterial ribosomes to inhibit protein synthesis. It demonstrates broad-spectrum activity against various gram-positive and gram-negative organisms, making it a valuable tool in microbiological research. Additionally, Spectinomycin sulfate hydrate acts as a noncompetitive inhibitor of td intron RNA, with a reported Ki value of 7.2 mM, further expanding its utility in molecular biology studies. -
Antibiotic
Parvodicin B1 is a glycopeptide antibiotic that exerts its antimicrobial effects by inhibiting bacterial cell wall synthesis. It demonstrates significant activity against Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus, and Enterococcus faecalis. Parvodicin B1 is valuable in microbiological research and antibiotic susceptibility studies, providing insights into bacterial resistance mechanisms and antibiotic efficacy. -
Antibiotic
Sch 29482 is an orally active penem antibiotic that exhibits broad-spectrum antibacterial activity. This compound demonstrates effectiveness against a variety of Gram-positive and Gram-negative bacteria, making it a valuable tool for research into antibacterial treatments. Its unique mechanism of action interferes with bacterial cell wall synthesis, providing insights into antibiotic efficacy and resistance mechanisms. -
Antibiotic
Methacycline is a tetracycline antibiotic that primarily inhibits bacterial protein synthesis. It is recognized for its capacity to impede epithelial-to-mesenchymal transition (EMT) in vitro and to inhibit fibrogenesis in vivo, functioning independently of TGF-β1 Smad signaling pathways. Methacycline serves as an antimicrobial agent and demonstrates potential applications in the study of pulmonary fibrosis. -
Antibiotic
Pristinamycin II B is an ester peptide antibiotic that primarily targets Gram-positive bacteria. It exhibits potent antibacterial activity, making it a valuable reagent in studies focused on the treatment of infections caused by resistant strains. This compound is commonly utilized in research applications related to antibiotic resistance and the development of novel antimicrobial therapies. -
Antibiotic
Helvolinic acid is a steroidal antibiotic that targets Gram-positive bacteria. This compound exhibits significant antibacterial activity, making it a valuable tool in the study of antimicrobial mechanisms and the development of new therapeutic agents. Its efficacy against resistant strains of bacteria positions it as a noteworthy reagent in antibiotic research and development. -
Antitumor Antibiotic
Menoxymycin B is an antitumor antibiotic that exhibits notable cytotoxic effects against cancer cells. It demonstrates potent inhibitory activity with IC50 values of 0.22 μM in KB cells and 0.023 μM in N18-RE-105 cells. This compound is valuable for cancer research, particularly in studies focused on cell proliferation and apoptosis mechanisms. -
Antibiotic
Minosaminomycin is an antibiotic that targets bacterial cells and is derived from the bacterium Streptomyces No. MA514A1. This compound demonstrates significant antimicrobial activity against Mycobacterium smegmatis ATCC 607 and Mycobacterium phlei, with minimum inhibitory concentrations (MIC) of 1.56 μg/mL and 6.25 μg/mL, respectively. Minosaminomycin is valuable for research applications focused on bacterial infections and the study of mycobacterial resistance. -
Antibiotic
Abbeymycin is an antibiotic derived from the actinobacterium Streptomyces sp. AB-999F-52, exhibiting potent antimicrobial activity primarily against anaerobic bacteria. Its specific action makes Abbeymycin a valuable tool in antibiotic discovery and screening research, aiding in the exploration of novel antimicrobial compounds. -
Antibiotic
Arylomycin B4 is a lipohexapeptide antibiotic specifically targeting Gram-positive bacteria. It demonstrates potent antimicrobial activity by inhibiting bacterial protein synthesis. This compound is valuable for research applications focused on the mechanisms of antibiotic resistance and the development of new antimicrobial agents. -
Antibiotic
Sapurimycin is an antitumor antibiotic derived from Streptomyces DO-116, belonging to the capramycin family. It demonstrates potent activity against Gram-positive bacteria and exhibits significant antitumor efficacy against leukemia P388 and sarcoma 180 in murine models. In vitro assays reveal that Sapurimycin induces single-strand breaks in supercoiled plasmid DNA, highlighting its potential utility in genomic studies and cancer research. -
Antibiotic
Cedarmycin A is an antibiotic with demonstrated efficacy against Candida species, Cryptococcus neoformans, and Aspergillus fumigatus, with minimum inhibitory concentration (MIC) values ranging from 12.5 to 50 μg/mL. It serves as a valuable research tool for investigating fungal infections and the development of antifungal therapies. Cedarmycin A's unique mechanism of action makes it an important compound for studying microbial resistance and host-pathogen interactions. -
Antitumor Antibiotic
Primocarcin is an antitumor antibiotic that specifically targets Ehrlich ascites carcinoma. Its mechanism of action involves the inhibition of tumor cell proliferation, making it a valuable compound for cancer research. Primocarcin is utilized in various studies aimed at understanding the efficacy of novel antitumor therapies and the biochemical pathways involved in cancer progression. -
Antibiotic
3''-Deamino-3''-hydroxykanamycin B is an antibiotic derived from the bacterium S. tenebrarius, specifically targeting bacterial ribosomes to inhibit protein synthesis. This compound exhibits notable effectiveness against Escherichia coli strains, including E. coli ATCC 25922 and E. coli CCARM 1A020, with minimum inhibitory concentration (MIC) values of 128 μg/mL. It is suitable for research applications involving antibiotic resistance and microbial susceptibility studies. -
Antibiotic
Eurocidin D is a cyclic peptide antibiotic that primarily targets and inhibits mast cell degranulation in rat models. This compound demonstrates significant anti-inflammatory properties, making it a valuable tool for studying allergic reactions and mast cell biology. Its unique mechanism of action positions it as a potential research candidate in understanding and treating conditions related to mast cell activation. -
Antibiotic
Lankacidinol is an antibiotic that exhibits significant biological activity against various pathogens. Its related metabolites, 2,18-seco-lankacidinol A and 2,18-seco-lankacidinol B, also demonstrate noteworthy medicinal properties. Notably, 2,18-seco-lankacidinol A has shown potent antitumor activity, making Lankacidinol a compound of interest for research in antibiotic and cancer therapeutics. -
Antibiotic
Oryzoxymycin is an aromatic derivative antibiotic targeting bacterial ribosomes to inhibit protein synthesis. This compound exhibits potent activity against Gram-negative bacteria, making it a valuable tool for studying antibiotic resistance mechanisms and bacterial infection pathways. It is applicable in research focused on microbial physiology and the development of new antibacterial agents. -
Antibiotic
BO-1165 is a potent antibiotic targeting Gram-negative bacteria with minimal efficacy against Gram-positive and anaerobic bacteria. It exhibits significant antibacterial activity against Pseudomonas aeruginosa, presenting a MIC50 of 3.12 mg/L, and against P. cepacia with a MIC50 of 1.56 mg/L. This compound is primarily utilized in research focused on combating infections caused by resistant Gram-negative pathogens. -
Antitumor Antibiotic
7-Hydroxyguanine is an antitumor antibiotic that primarily targets nucleic acid synthesis. It exhibits significant cytotoxicity against L1210 leukemia cells, effectively inhibiting their growth. This compound is utilized in cancer research to study mechanisms of action related to nucleobase analogs and their potential therapeutic applications. -
Antibiotic
Mikanolide is a sesquiterpene with notable antibacterial activity, primarily targeting Staphylococcus aureus. Demonstrating effective growth inhibition, it produces a zone of inhibition of 14 mm when tested at a concentration of 100 μg per disk. This compound may serve as a valuable tool in antibiotic research and the study of bacterial resistance mechanisms. -
Antibiotic
Dermadin is an antibiotic that targets bacterial infections through its antibacterial mechanisms. It exhibits significant antibacterial activity, making it suitable for research applications aimed at understanding and combating bacterial infections. This compound is particularly useful in studies focusing on antibiotic resistance and the development of new antimicrobial therapies. -
Antibiotic
Adenomycin is an antibiotic with a primary mechanism of action targeting mycobacteria. It demonstrates significant antimicrobial activity against a broad spectrum of mycobacterial species, making it a valuable reagent in research focused on mycobacterial infections and antibiotic resistance. Its efficacy in inhibiting mycobacterial growth facilitates studies in microbiology and drug development. -
Antitumor Antibiotic
16-Methyloxazolomycin is an antitumor antibiotic that exhibits significant antibacterial and antifungal activity. It has demonstrated efficacy against leukemia P388 cells and human lung adenocarcinoma cells, making it a valuable tool for cancer research and therapeutic development. This compound is utilized in the study of tumor biology and the exploration of novel therapeutic approaches in oncology. -
Antibiotic
Fluvirucin B1 is an antibiotic primarily targeting the influenza A virus. It exhibits potent antiviral activity by inhibiting viral replication, making it a valuable tool for research on influenza pathogenesis and antiviral drug development. Its efficacy in combating influenza A can aid in exploring therapeutic interventions in related viral infections. -
Antibiotic
Espinomycin A3 is a sixteen-membered macrolide antibiotic that targets bacterial protein synthesis, specifically inhibiting peptide elongation. It exhibits potent activity against Gram-positive bacteria, making it a valuable tool for research in antimicrobial mechanisms and antibiotic resistance. This compound is useful for studies focused on discovering new treatments for bacterial infections. -
Antitumor Antibiotic
13-Hydroxyglucopiericidin A is an antitumor antibiotic that exhibits potent cytotoxic activity against various cancer cell lines. Its mechanism involves inhibiting key cellular processes essential for tumor growth and proliferation. This compound is valuable for research in cancer biology and the development of novel therapeutic strategies targeting tumor cells. -
Antibiotic
3,6-Dihydroxyindoxazene is an antibiotic that demonstrates selective activity against Gram-negative bacteria. Isolated from Chromobacterium violaceum, it serves as a valuable tool in the study of bacterial resistance and antibiotic efficacy. Its unique mechanism of action provides insights into the development of new antimicrobial strategies and treatments. -
Antibiotic
Glycothiohexide α is a peptide antibiotic that targets bacterial cell wall synthesis. It exhibits potent activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VREF), with minimum inhibitory concentration (MIC) values ranging from 0.03 to 0.06 μg/mL. This compound is valuable for research into antibiotic resistance and developing new therapeutic strategies against resistant infections. -
Bacterial Metabolite
Aklaviketone is a bacterial metabolite derived from the strain S 383 of Streptomyces galilaeus. This compound plays a crucial role in the biosynthetic pathway of anthracycline antibiotics, contributing to their formation and activity. Aklaviketone is valuable for research applications focused on antibiotic synthesis and microbial metabolism. -
Antibiotic
Lenapenem, a carbapenem antibiotic, exhibits potent antibacterial activity against both Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa. This compound is utilized in research applications aimed at exploring bacterial resistance mechanisms and developing new antimicrobial strategies. Its efficacy against a broad spectrum of pathogens makes it a valuable tool for studying antibiotic pharmacodynamics and pharmacokinetics. -
Antibiotic
10'-Desmethoxystreptonigrin is an antibiotic that acts as an inhibitor of Ras Farnesyltransferase, exhibiting an IC50 of 21 μM. This compound demonstrates broad-spectrum antibacterial activity and shows antitumor effects against P388 leukemia, with an LD50 of 8.8 mg/kg indicating minimal cytotoxicity. It is a valuable reagent for research applications targeting antibiotic resistance and cancer therapeutics. -
Antibiotic
Acetylstachyflin is an antibiotic with demonstrated efficacy against Influenza A virus. Its primary mechanism involves targeting viral replication, thereby inhibiting the spread of the virus within host cells. This compound is valuable for research applications focused on antiviral drug development and understanding influenza pathogenesis.
